BioVentrix Launches Novel Revivent Myocardial Anchoring System at Renowned European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
25 oct. 2012 08h35 HE
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) - Techno-College Booth 005; EACTS Booth 92/93 - BioVentrix, the developer of minimally invasive heart failure therapies, today introduced the...
BioVentrix lance son nouveau système d'ancrage myocardique Revivent à l'occasion de la réunion annuelle réputée de l'Association Européenne pour la Chirurgie Cardio-Thoracique (EACTS)
25 oct. 2012 03h35 HE
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) -
Stand Techno-College 005 ; Stand EACTS 92/93 - BioVentrix, le développeur de traitements mini-invasifs contre les insuffisances...
BioVentrix lanceert nieuw Revivent Myocardial Anchoring Systeem op de jaarlijkse bijeenkomst van de vermaarde Europese Associatie voor Thoraxchirurgie (EACTS)
25 oct. 2012 03h35 HE
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) -
Techno-College Stand 005; EACTS Stand 92/93 - BioVentrix, de ontwikkelaar van minimaal invasieve hartfalen therapieën, introduceerde vandaag...
BioVentrix lanciail nuovo sistema di ancoraggio del miocardio Reviventin occasione del congresso annuale della prestigiosaEuropean Association for Cardio-Thoracic Surgery (EACTS)
25 oct. 2012 03h35 HE
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) -
Stand Techno-College005; stand EACTS 92/93 - BioVentrix, azienda operante nel settore dello sviluppo di terapie per l'insufficienza cardiaca...
BioVentrix führt im Rahmen der Jahresversammlung der European Association for Cardio-Thoracic Surgery (EACTS) ein neues Revivent-System zur Verankerung im Herzmuskel ein
25 oct. 2012 03h35 HE
|
BioVentrix
BARCELONA, SPAIN--(Marketwire - Oct 25, 2012) -
Techno-College-Stand 005; EACTS-Stand 92/93 – BioVentrix, der Entwickler von minimalinvasiven Herzinsuffizienztherapien, stellte heute das...
BioVentrix lanza novedoso sistema de anclaje del miocardio Revivent en la reunión anual de la célebre Asociación Europea de Cirugía Cardiotorácica (EACTS)
25 oct. 2012 03h35 HE
|
BioVentrix
BARCELONA, ESPAÑA--(Marketwire - Oct 25, 2012) -
Stand 005 Techno-College; Stand 92/93 de EACTS - BioVentrix, el desarrollador de terapias mínimamente invasivas para el tratamiento de...
BioVentrix Reports Favorable Patient Outcomes for Heart Failure Treatment at TCT 2012
23 oct. 2012 08h35 HE
|
BioVentrix
SAN RAMON, CA--(Marketwire - Oct 23, 2012) - Results from a clinical abstract to be presented at the TCT 2012 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the...
BioVentrix Initiates Phase II Study of Revivent System for Less Invasive Heart Failure Treatment in Western Europe
03 oct. 2012 08h29 HE
|
BioVentrix
SAN RAMON, CA--(Marketwire - Oct 3, 2012) - BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, today announced the initiation of a Phase II clinical trial...
BioVentrix Announces Newly Elected Members to Board of Directors
18 juin 2012 08h35 HE
|
BioVentrix
SAN RAMON, CA--(Marketwire - Jun 18, 2012) - BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, announced the election of Mr. George J. Fazio and Mr....
BioVentrix geselecteerd om op prestigieuze EuroPCR-bijeenkomst te presenteren
14 mai 2012 08h00 HE
|
BioVentrix
PARIS--(Marketwire - May 14, 2012) -
BioVentrix, de ontwikkelaar van minimaal invasieve therapieën voor de behandeling van hartinfarcten, werd geselecteerd om te presenteren tijdens EuroPCR,...